Isogen's new science centre a "unique" clinical service facility
US firm Isogen says the combination of aseptic filling, engineering and containment know-how on offer at its new Science Center is unique among facilities serving the clinical market.
Archives for July 27, 2009
KV hires restructuring and bankruptcy firm
KV Pharmaceutical has hired a firm specialising in restructuring and bankruptcy and said “there are significant uncertainties regarding its ability to continue as a going concern during the upcoming fiscal year”.
Rexam considers rights issue, market remains weak
Beauty packaging specialist Rexam is considering issuing new equity to service its burdensome debt pile, after market conditions failed to improve in the last quarter.
Phase Forward's income drops in Q2
Phase Forward’s GAAP net income fell by 41 per cent in Q2 despite an increase in revenues, as rising operating costs hit the company.
Sanofi may sell Alnwick R&D facility
French drugmaker Sanofi-Aventis may put its Alnwick Research Centre in Northumberland, UK up for sale, according various media reports.
Appointments at Novavax, Halozyme and Abraxis – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharmaceutical sector, including appointments at Novavax, Halozyme and Abraxis.
Indian clinical trial site closed over fraud
Glenmark Pharmaceuticals and Omnicare have closed a clinical trial site in India operated by the contract research organisation (CRO) amid accusations that an investigator acted fraudulently.